新一代DES的抗血小板治疗 PPT.pptxVIP

  1. 1、本文档共43页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Anti-platelet therapy for new generation DES disclosureI have nothing to disclosure regarding this lecture 1st degeneration DES has demonstrated its’ superior efficacy But safety is always a dark cloud ……BASKET LATE Trial: 6-18 Mo MACE N=743 (pts with early events excluded) Rationales for prolonged antiplatelet therapy post DES implantation48 months40 mosBMSDESIncompleteappositionLate stentthrombosisAngioscopyBMSDESEosGiant cellsIVUSAbn Vasomotion*P0.001 vs. controlSirolimus Control ** Rationales for prolonged antiplatelet therapy post DES implantationCYPHER?TAXUS? Cypher Stent? Launch2003AHA/ACC Guidelines 2001(9-12 months post PCI)(TAXUS stent 6 months post PCI)(Cypher stent 3 months post PCI)AHA/ACC/SCAIUpdated Guidelines 2005ESC PCIUpdated Guidelines 2005(6-12 months post PCI)Optimal Duration of Anti-platelet Therapy Post DES Still UnclearBMS EraDES EraCURE (PCI-CURE)200111 yearTAXUS? Express2TM Stent Launch2004Latest FDA, ACC/AHA/SCAI Recommendations 2006(1 year post PCI in pts at low risk of bleeding Clinical scenarios need early cessation of anti-platelet therapy What’s new in new generation DES ?Stent platform Everolimus-Eluting StentsXIENCE V / PROMUS (CoCr-EES)PROMUS Element (PtCr-EES)PBMA=poly (n?butyl methacrylate) (primer layer); PVDF-HFP=poly vinylidene fluoride?co?hexafluoropropylene) (drug matrix layer) 33% Platinum37% Iron18% Chromium9% Nickel0.05% Manganese2.6% Molybdenum20% Chromium52% Cobalt15% Tungsten10% Nickel1.5% Manganese3% Iron XIENCE V / PROMUS Everolimus-eluting Stent ML VISION? Stent PlatformDurable Fluorinated CopolymerML VISION? Stent Delivery SystemEverolimus Endeavor DES SystemPC TechnologyDrug: ZotarolimusStent Delivery SystemDriver Cobalt Alloy Stent DES strut and polymerStrut Thickness:81 mmPolymer Thickness:7.8 mmTotal:96.6 umStrut Thickness:91 mmPolymer Thickness:5.3 mmTotal:101.6 umStrut Thickness:132 mmPolymer Thickness:16 mmTotal:164 umStrut Thickness:140 mmPolymer Thickness:12.6 mmTotal:165.2 umXIENCE? VCYPHER?TAXUS?EN

文档评论(0)

ning2021 + 关注
实名认证
文档贡献者

中医资格证持证人

该用户很懒,什么也没介绍

领域认证该用户于2023年05月10日上传了中医资格证

1亿VIP精品文档

相关文档